BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sun L, Dong Z, Gu H, Guo Z, Yu Z. TINAGL1 promotes hepatocellular carcinogenesis through the activation of TGF-β signaling-medicated VEGF expression. Cancer Manag Res 2019;11:767-75. [PMID: 30697069 DOI: 10.2147/CMAR.S190390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Tian WQ, Chen SY, Chuan FN, Zhao WR, Zhou B. Down-regulated TINAGL1 in fibroblasts impairs wound healing in diabetes. FASEB J 2022;36:e22235. [PMID: 35199864 DOI: 10.1096/fj.202101438RR] [Reference Citation Analysis]
2 Bisogno LS, Yang J, Bennett BD, Ward JM, Mackey LC, Annab LA, Bushel PR, Singhal S, Schurman SH, Byun JS, Nápoles AM, Pérez-Stable EJ, Fargo DC, Gardner K, Archer TK. Ancestry-dependent gene expression correlates with reprogramming to pluripotency and multiple dynamic biological processes. Sci Adv 2020;6:eabc3851. [PMID: 33219026 DOI: 10.1126/sciadv.abc3851] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Musetti SN, Huang L. Tinagl1 Gene Therapy Suppresses Growth and Remodels the Microenvironment of Triple Negative Breast Cancer. Mol Pharm 2021;18:2032-8. [PMID: 33877834 DOI: 10.1021/acs.molpharmaceut.1c00008] [Reference Citation Analysis]
4 Akaiwa M, Fukui E, Matsumoto H. Tubulointerstitial nephritis antigen-like 1 deficiency alleviates age-dependent depressed ovulation associated with ovarian collagen deposition in mice. Reprod Med Biol 2020;19:50-7. [PMID: 31956285 DOI: 10.1002/rmb2.12301] [Reference Citation Analysis]
5 Zuo Y, Lu Y, Xu Q, Sun D, Liang X, Li X, Li Y. Inhibitory effect of dihydromyricetin on the proliferation of JAR cells and its mechanism of action. Oncol Lett 2020;20:357-63. [PMID: 32565961 DOI: 10.3892/ol.2020.11546] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]